Skip to main content
Log in

The Synergic In Vitro Tocolytic Effect of Nifedipine Plus Ritodrine on Human Myometrial Contractility

  • Original Article
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

Many pharmacological agents have been investigated to manage preterm labor; we postulate that a combination of tocolytic drugs may achieve a better effect in the prevention of uterine contractions without dose-dependent adverse effects. The aim of this study was to evaluate the inhibitory effect of dual combinations of tocolytics in vitro. Human myometrium was obtained during elective cesarean sections (term without labor; n = 40). Myometrial strips were placed in organ baths for the measurement of isometric tension. Contractile activity was induced by oxytocin (10−8 mol/L), then a concentration-response curve to single or dual combinations of tocolytics was started. All studied tocolytics (nifedipine, ritodrine, nitroglycerin, atosiban, and NS-1619), when used alone, significantly inhibited myometrial contractions. When combined, nifedipine plus ritodrine produced a significantly greater inhibition of contractility than each drug alone in the midrange of concentrations. The combination of nifedipine plus nitroglycerin or nifedipine plus atosiban produced a significantly greater inhibition than nitroglycerin or atosiban alone but not greater than nifedipine. The combination of nifedipine plus NS-1619 (Ca+2-activated K+ [BKCa] channel opener) reduced the inhibitory effect of each drug. We concluded that a selected combination of tocolytics (nifedipine plus ritodrine) produced a significantly greater inhibitory effect on contractility than each drug alone at intermediate concentrations. Thus, specific combinations of tocolytics with different intracellular signaling pathways may have a synergic effect constituting a provocative new option for preterm labor treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Barros FC, Papageorghiou AT, Victora CG, et al. International Fetal and Newborn Growth Consortium for the 21st Century. The distribution of clinical phenotypes of preterm birth syndrome: implications for prevention. JAMA Pediatr. 2015;169(3):220–229.

    Article  PubMed  Google Scholar 

  2. Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet. 2008;371(9608):261–269.

    PubMed  Google Scholar 

  3. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75–84.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Norwitz ER, Robinson JN, Challis JR. The control of labor. N Engl J Med. 1999;341(9):660–666.

    Article  CAS  PubMed  Google Scholar 

  5. Akerlund M, Carlsson AM, Melin P, Trojnar J. The effect on the human uterus of two newly developed competitive inhibitors of oxytocin and vasopressin. Acta Obstet Gynecol Scand. 1985;64(6):499–504.

    Article  CAS  PubMed  Google Scholar 

  6. Lees C, Campbell S, Jauniaux E, et al. Arrest of preterm labour and prolongation of gestation with glyceryl trinitrate, a nitric oxide donor. Lancet. 1994;343(8909):1325–1326.

    Article  CAS  PubMed  Google Scholar 

  7. Liu YL, Nwosu UC, Rice PJ. Relaxation of isolated human myometrial muscle by beta2-adrenergic receptors but not beta1-adrenergic receptors. Am J Obstet Gynecol. 1998;179(4):895–898.

    Article  CAS  PubMed  Google Scholar 

  8. Nassar AH, Aoun J, Usta IM. Calcium channel blockers for the management of preterm birth: a review. Am J Perinatol. 2011;28(1):57–66.

    Article  PubMed  Google Scholar 

  9. Olesen SP, Munch E, Moldt P, Drejer J. Selective activation of Ca(2+)-dependent K+ channels by novel benzimidazolone. Eur J Pharmacol. 1994;251(1):53–59.

    Article  CAS  PubMed  Google Scholar 

  10. Berkman ND, Thorp JM Jr, Lohr KN, et al. Tocolytic treatment for the management of preterm labor: a review of the evidence. Am J Obstet Gynecol. 2003;188(6):1648–1659.

    Article  CAS  PubMed  Google Scholar 

  11. Petousis S, Margioula-Siarkou C, Kalogiannidis I. Effectiveness of tocolytic agents on prevention of preterm delivery, neonatal morbidity, and mortality: is there a consensus? A review of the literature. Obstet Gynecol Surv. 2016;71(4):243–252.

    Article  PubMed  Google Scholar 

  12. Carvajal JA. Parto Prematuro. In: Pérez Sánchez A, Donoso E, eds. Obstetricia. Cuarta Edición ed. Santiago, CL: Editorial Mediterráneo Ltda; 2011:717–744.

    Google Scholar 

  13. Doret M, Mellier G, Gaucherand P, et al. The in vitro effect of dual combinations of ritodrine, nicardipine an atosiban on contractility of pregnant rat myometrium. BJOG. 2003;110(8):731–734.

    Article  CAS  PubMed  Google Scholar 

  14. Kuc P, Laudanski P, Pierzynski P, Laudanski T. The effect of combined tocolysis on in vitro uterine contractility in preterm labour. Adv Med Sci. 2011;56(1):88–94.

    Article  CAS  PubMed  Google Scholar 

  15. Haas DM, Caldwell DM, Kirkpatrick P, McIntosh JJ, Welton NJ. Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ. 2012;345:e6226.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Carvajal JA, Buhimschi IA, Thompson LP, Aguan K, Weiner CP. Chorion releases a factor that inhibits oxytocin-stimulated myo-metrial contractility in the pregnant guinea pig. Hum Reprod. 2001;16(4):638–643.

    Article  CAS  PubMed  Google Scholar 

  17. Chiossi G, Costantine MM, Betancourt A, et al. Does sildenafil citrate affect myometrial contractile response to nifedipine in vitro? Am J Obstet Gynecol. 2010;252(3):252.e1-e5.

    Google Scholar 

  18. David M, Hamann C, Chen FC, Bruch L, Lichtenegger W. Comparison of the relaxation effect in vitro of nitroglycerin vs. fenoterol on human myometrial strips. J Perinat Med. 2000;28(3):232–242.

    Article  CAS  PubMed  Google Scholar 

  19. Sakakibara T, Inoue Y, Uzue S, et al. Diversity of inhibitory responses to beta2-stimulants shown by term-pregnant human myometria in vitro is partly due to differences in receptor density. Am J Obstet Gynecol. 2002;186(5):997–1004.

    Article  CAS  PubMed  Google Scholar 

  20. Khan RN, Smith SK, Ashford ML. Contribution of calcium-sensitive potassium channels to NS1619-induced relaxation in human pregnant myometrium. Hum Reprod. 1998;13(1):208–213.

    Article  CAS  PubMed  Google Scholar 

  21. Moynihan AT, Smith TJ, Morrison JJ. The relaxant effect of nifedipine in human uterine smooth muscle and the BK(Ca) channel. Am J Obstet Gynecol. 2008;237(2):237.e1-e8.

    Google Scholar 

  22. Carvajal JA, Germain AM, Huidobro-Toro JP, Weiner CP. Molecular mechanism of cGMP-mediated smooth muscle relaxation. J Cell Physiol. 2000;184(3):409–420.

    Article  CAS  PubMed  Google Scholar 

  23. Yallampalli C, Dong YL, Gangula PR, Fang L. Role and regulation of nitric oxide in the uterus during pregnancy and parturition. J Soc Gynecol Investig. 1998;5(2):58–67.

    Article  CAS  PubMed  Google Scholar 

  24. Duckitt K, Thornton S, O’Donovan OP, Dowswell T. Nitric oxide donors for treating preterm labour. Cochrane Database Syst Rev. 2014;(5):CD002860.

    Google Scholar 

  25. Husslein P, Cabero Roura L, Dudenhausen JW, et al. Atosiban versus usual care for the management of preterm labor. J Perinat Med. 2007;35(4):305–313.

    Article  PubMed  Google Scholar 

  26. Saez V, Germain AM, Carvajal JA. Atosiban, perspectivas sobre el manejo etiológico del parto prematuro. Rev Chil Obstet Gine-col. 2002;67(3):249–255.

    Google Scholar 

  27. Flenady V, Reinebrant HE, Liley HG, Tambimuttu EG, Papatso-nis DN. Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database Syst Rev. 2014;(6):CD004452.

    Google Scholar 

  28. Group EAS. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor a randomized, double-blind, controlled study. Acta Obstet Gynecol Scand. 2001;80(5):413–422.

    Google Scholar 

  29. Moutquin JM, Sherman D, Cohen H, et al. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. Am J Obstet Gynecol. 2000;182(5):1191–1199.

    Article  CAS  PubMed  Google Scholar 

  30. Salim R, Garmi G, Nachum Z, Zafran N, Baram S, Shalev E. Nifedipine compared with atosiban for treating preterm labor: a randomized controlled trial. Obstet Gynecol. 2012;120(6):1323–1331.

    Article  CAS  PubMed  Google Scholar 

  31. Lorca RA, Prabagaran M, England SK. Functional insights into modulation of BKCa channel activity to alter myometrial contractility. Front Physiol. 2014;5:289.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Miller C. An overview of the potassium channel family. Genome Biol. 2000;1(4):REVIEWS0004.

    Google Scholar 

  33. Yamamura H, Ohi Y, Muraki K, Watanabe M, Imaizumi Y. BK channel activation by NS-1619 is partially mediated by intracel-lular Ca2+ release in smooth muscle cells of porcine coronary artery. Br J Pharmacol. 2001;132(4):828–834.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Vasudevan NT, Mohan ML, Goswami SK, Naga Prasad SV. Regulation of beta-adrenergic receptor function: an emphasis on receptor resensitization. Cell Cycle. 2011;10(21):3684–3691.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Yuan W, Lopez Bernal A. Cyclic AMP signalling pathways in the regulation of uterine relaxation. BMC Pregnancy Childbirth. 2007;7(suppl 1):S10.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Hubinont C, Debieve F. Prevention of preterm labour: 2011 update on tocolysis. J Pregnancy. 2011;2011:941057.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Yaju Y, Nakayama T. Effectiveness and safety of ritodrine hydro-chloride for the treatment of preterm labour: a systematic review. Pharmacoepidemiol Drug Saf. 2006;15(11):813–822.

    Article  CAS  PubMed  Google Scholar 

  38. Neilson JP, West HM, Dowswell T. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev. 2014;(2): CD004352.

    Google Scholar 

  39. Flenady V, Wojcieszek AM, Papatsonis DN, et al. Calcium channel blockers for inhibiting preterm labour and birth. Cochrane Database Syst Rev. 2014;(6):CD002255.

    Google Scholar 

  40. Kim MJ, Hwang I, Bae JY, Seong WJ. The influence of ritodrine alone or in combination with nifedipine on maternal cardiovascular side effects and pregnancy outcomes. Clin Exp Obstet Gynecol. 2014;41(5):537–540.

    CAS  PubMed  Google Scholar 

  41. Vogel JP, Nardin JM, Dowswell T, West HM, Oladapo OT. Combination of tocolytic agents for inhibiting preterm labour. Cochrane Database Syst Rev. 2014;(7):CD006169.

    Google Scholar 

  42. Brown RG, MacIntyre DA. Calcium channel blockers are effective as first line for tocolysis in the management of preterm labour. Evid Based Med. 2014;214(6):214.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jorge Andrés Carvajal MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Carvajal, J.A., Zambrano, M.J., Theodor, N.M. et al. The Synergic In Vitro Tocolytic Effect of Nifedipine Plus Ritodrine on Human Myometrial Contractility. Reprod. Sci. 24, 635–640 (2017). https://doi.org/10.1177/1933719116667221

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719116667221

Keywords

Navigation